The plus score as a dual-domain predictor of delayed cerebral ischemia and mortality after aneurysmal subarachnoid hemorrhage

加分评分作为动脉瘤性蛛网膜下腔出血后迟发性脑缺血和死亡率的双域预测指标

阅读:2

Abstract

Delayed cerebral ischemia(DCI) is a major contributor to poor outcomes after aneurysmal subarachnoid hemorrhage(SAH), primarily due to symptomatic vasospasm. Accurate early risk stratification is essential for optimizing monitoring and treatment. Two commonly used predictors are the World Federation of Neurosurgical Societies(WFNS) clinical grade and the modified Fisher radiographic grade. We assessed whether the simple arithmetic sum of these two scores—termed the “Plus score”—could improve the prediction of DCI and mortality. We retrospectively reviewed the consecutive patients treated with surgical clipping at a single tertiary center from 2021 to 2025. Inclusion required angiographically confirmed aneurysmal hemorrhage, clipping within 72 h, and ≥ 6 months of follow-up. DCI was defined as a new neurological deterioration between post-SAH day 3–15, excluding the other causes. Logistic regression and receiver operating characteristic(ROC) analysis were used to compare the predictive performance of the WFNS grade, modified Fisher grade, and Plus score. Fifty-nine patients (mean age 53 ± 14 years; 52% female) were included. DCI occurred in 32 patients(54%), and in-hospital mortality was 16.9%. The mean Plus score was significantly higher in patients with DCI than those without, and higher in non-survivors than survivors. The Plus score showed superior predictive value for DCI (AUC = 0.748; cutoff ≥ 4.5: sensitivity = 84.4%, specificity = 55.2%) compared to WFNS (AUC = 0.704) and modified Fisher (AUC = 0.703) scores. For mortality prediction, the Plus score had an AUC of 0.870. The Plus score, combining neurological and radiographic severity into a single value, offers improved risk prediction for DCI and moderate accuracy for mortality. Its simplicity and clinical accessibility make it a valuable bedside tool for early stratification and targeted care in patients with aneurysmal subarachnoid hemorrhage. GRAPHICAL ABSTRACT: [Image: see text]

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。